PERITONEAL DIALYSIS
Clinical trials for PERITONEAL DIALYSIS explained in plain language.
Never miss a new study
Get alerted when new PERITONEAL DIALYSIS trials appear
Sign up with your email to follow new studies for PERITONEAL DIALYSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New dialysis solution may delay need for full treatment in kidney patients
Disease control Recruiting nowThis trial investigates whether using icodextrin, a special dialysis solution, can help people on peritoneal dialysis (a type of home dialysis for kidney failure) stay on a lower-dose regimen for longer. Participants are randomly assigned to receive either icodextrin or a standar…
Matched conditions: PERITONEAL DIALYSIS
Phase: PHASE4 • Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Can a new iron strategy help kidney dialysis patients fight anemia?
Disease control Recruiting nowThis study looks at different ways to give iron to people with kidney failure who are on peritoneal dialysis. Participants will get either high-dose or low-dose intravenous iron, or oral iron tablets. The main goal is to see if a larger trial is possible by checking how many peop…
Matched conditions: PERITONEAL DIALYSIS
Phase: PHASE3 • Sponsor: Hull University Teaching Hospitals NHS Trust • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can a common water pill help dialysis patients control blood pressure?
Disease control Recruiting nowThis study tests whether thiazide diuretics (water pills) can lower blood pressure in people on peritoneal dialysis who have high blood pressure. About 40 adults with end-stage kidney disease will take the drug and have their blood pressure, weight, and body fluid levels measured…
Matched conditions: PERITONEAL DIALYSIS
Phase: PHASE4 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New tablet could scratch the itch for dialysis patients
Symptom relief Recruiting nowThis study tests whether nalfurafine hydrochloride tablets can safely reduce moderate-to-severe itching in people undergoing peritoneal dialysis. About 93 participants will take the drug daily for up to 4 weeks, and their itch levels will be measured using a simple 0-to-10 scale.…
Matched conditions: PERITONEAL DIALYSIS
Phase: NA • Sponsor: Guangdong Provincial People's Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 13:02 UTC